Please assess the completion status of the following clinical trial:

Trial Title: Comparing Omeprazole With Fluoxetine for Treatment of Non Erosive Reflux Disease and Its Subgroups: a Double-blind Placebo-controlled Clinical Trial

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2/PHASE3
- Number of Arms: 6.0

Eligibility Criteria:
Inclusion Criteria:~* age above 18 and below 60 years old~* experiencing heartburn during last 6 months before inclusion~* experiencing heartburn during at least 4 of 7 days before inclusion~* presence of normal mucosa in upper gastrointestinal(GI) endoscopy which has been documented during 7 days before inclusion provided that the patient has not administered any PPI during last 30 days before inclusion~Exclusion Criteria:~* inability to undergone upper GI endoscopy or PH monitoring~* presence of barret's esophagus or erosive esophagitis in upper GI endoscopy~* presence of active peptic ulcer disease or any disease which affects the absorption of drugs such as inflammatory bowel disease~* past history of esophageal or gastric surgery~* esophageal stricture which needs dilation~* administration of proton pomp inhibitors during 30 days before inclusion to the study~* administration of H2 blockers, anticholinergics, sucralfate and pro-kinetics during the assessments for eligibility and also during the study~* long time administration of non-steroidal anti-inflammatory drugs (NSAIDs)~* administration of neuroleptic or antidepressant drugs during 30 days before inclusion to the study~* known allergy to PPIs or SSRIs~* presence of significant systemic disease such as scleroderma , diabet mellitus , peripheral and autonomic neuropathies and ...~* pregnancy for females~* presence of known psychiatric disorder such as depression , panic disorder or drug addiction according to the DSM-IV criteria

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 60 Years
- Healthy Volunteers: f

Study Arms:
- pH positive-omeprazole (Type: ACTIVE_COMPARATOR): None
- pH positive-placebo (Type: PLACEBO_COMPARATOR): None
- pH positive-fluoxetine (Type: ACTIVE_COMPARATOR): None
- pH negative-omeprazole (Type: ACTIVE_COMPARATOR): None
- pH negative-fluoxetine (Type: ACTIVE_COMPARATOR): None
- pH negative-placebo (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).